PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis
Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). Methods PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies...
Saved in:
Published in | European journal of nuclear medicine and molecular imaging Vol. 52; no. 6; pp. 2212 - 2224 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1619-7070 1619-7089 1619-7089 |
DOI | 10.1007/s00259-025-07069-6 |
Cover
Abstract | Purpose
To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).
Methods
PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the
I
2
value. Subgroup analyses were conducted to explore sources of heterogeneity.
Results
Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an
I
2
of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity.
Conclusions
This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC. |
---|---|
AbstractList | PurposeTo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).MethodsPubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.ResultsTwelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity.ConclusionsThis meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC. Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). Methods PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I 2 value. Subgroup analyses were conducted to explore sources of heterogeneity. Results Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I 2 of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity. Conclusions This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC. To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I value. Subgroup analyses were conducted to explore sources of heterogeneity. Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity. This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC. To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).PURPOSETo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.METHODSPubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity.RESULTSTwelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity.This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.CONCLUSIONSThis meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC. |
Author | Zhang, Xiaohui Zhong, Yan Zhong, Chao Xiao, Meiling Zhang, Hong Zhang, Jucheng Chen, Yuhan Wang, Jing |
Author_xml | – sequence: 1 givenname: Jucheng surname: Zhang fullname: Zhang, Jucheng organization: Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province – sequence: 2 givenname: Xiaohui surname: Zhang fullname: Zhang, Xiaohui organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University – sequence: 3 givenname: Yan surname: Zhong fullname: Zhong, Yan organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University – sequence: 4 givenname: Jing surname: Wang fullname: Wang, Jing organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University – sequence: 5 givenname: Chao surname: Zhong fullname: Zhong, Chao organization: Department of Radiology, Ningbo Yinzhou NO.2 Hospital – sequence: 6 givenname: Meiling surname: Xiao fullname: Xiao, Meiling organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University – sequence: 7 givenname: Yuhan surname: Chen fullname: Chen, Yuhan organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University – sequence: 8 givenname: Hong orcidid: 0000-0002-4084-5150 surname: Zhang fullname: Zhang, Hong email: hzhang21@zju.edu.cn organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University, Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, College of Biomedical Engineering & Instrument Science, Zhejiang University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39794511$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1vFSEUxYmpsV_-Ay4MiRs32AvMwODONPUjaVIX7ZowDDxpZoYnd6b6_nt5vloTF24OLH4Hzr3nlBzNeQ6EvOLwjgPoCwQQrWFVGGhQhqln5IQrbpiGzhw93TUck1PEewDeic68IMfSaNO0nJ-Qn1-vbmlxQ8pT8khjLvRbwiWPeZM8xbVfdttA_egQU0zeLSnPNEdaozCc3DhSH6qM67yh3s0-lPfUUdzhEqYKe1rCQwo_qJsHOoXFMTe7cYcJz8nz6EYMLx_PM3L38er28jO7vvn05fLDNfNSqIV5IQbwDejBi25olYyaG3C85y42nTGtA-hdr1svlIja9X0djUevlWi8iFyekbeHd7clf18DLnZKuM_s5pBXtJK3TQOy7qaib_5B7_Naat49ZWSjFG9kpV4_Ums_hcFuS5pc2dk_O62AOAC-ZMQS4hPCwe6Ls4fibBX7uzirqkkeTFjheRPK37__4_oF6d2a-Q |
Cites_doi | 10.3322/caac.21834 10.1053/j.semnuclmed.2022.04.010 10.1016/j.mayocp.2019.01.013 10.1259/bjr.20220339 10.1007/s11307-016-0940-2 10.2147/CMAR.S287128 10.1136/bmj.315.7109.629 10.2967/jnumed.118.217612 10.1148/radiol.212798 10.1016/j.bspc.2021.102446 10.18383/j.tom.2019.00031 10.1007/s00259-022-06001-6 10.1016/j.compbiomed.2024.108461 10.1007/s00259-020-05065-6 10.1016/j.acra.2023.03.032 10.3389/fonc.2022.875761 10.1002/ima.22858 10.1007/s00259-017-3865-3 10.3389/fonc.2022.991102 10.1007/s00259-021-05220-7 10.1007/s00330-020-06957-9 10.1016/S1470-2045(20)30751-8 10.3389/fonc.2022.803824 10.3906/elk-1810-154 10.1109/JBHI.2022.3192010 10.1016/S1470-2045(20)30108-X 10.7326/0003-4819-155-8-201110180-00009 10.1109/ACCESS.2020.3040155 10.1007/s00330-017-5221-1 10.1097/JTO.0b013e318226b677 10.1088/1361-6560/aad648 10.1002/mp.13678 10.21203/rs.3.rs-2393890/v1 10.1634/theoncologist.2008-0232 10.1371/journal.pone.0300170 10.1038/nrclinonc.2017.141 10.1136/bmj.b605 10.1136/bmjopen-2021-056804 10.1038/s41591-021-01450-2 10.21037/tcr.2019.08.20 10.1016/j.clon.2023.08.003 10.1007/s00259-020-04771-5 10.21037/qims-20-1182 10.3389/fonc.2021.633176 10.1007/s11547-023-01621-w 10.1136/bmj.n160 10.1097/RLU.0000000000002810 10.1007/s00259-021-05234-1 10.3322/caac.21820 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. Copyright Springer Nature B.V. May 2025 |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. – notice: Copyright Springer Nature B.V. May 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. NAPCQ 7X8 |
DOI | 10.1007/s00259-025-07069-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1619-7089 |
EndPage | 2224 |
ExternalDocumentID | 39794511 10_1007_s00259_025_07069_6 |
Genre | Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 32027802 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: Key Research and Development Program of Zhejiang Province grantid: 2022C03071; 2022C03111; 2023C03088 funderid: http://dx.doi.org/10.13039/100022963 – fundername: Fundamental Research Funds for the Central Universities grantid: Fundamental Research Funds for the Central Universities funderid: http://dx.doi.org/10.13039/501100012226 – fundername: Key Research and Development Program of Zhejiang Province grantid: 2023C03088 – fundername: National Natural Science Foundation of China grantid: 32027802 – fundername: Key Research and Development Program of Zhejiang Province grantid: 2022C03071 – fundername: Fundamental Research Funds for the Central Universities grantid: Fundamental Research Funds for the Central Universities – fundername: Key Research and Development Program of Zhejiang Province grantid: 2022C03111 |
GroupedDBID | --- -Y2 -~C .86 .GJ 04C 06C 06D 0R~ 0VY 1N0 29G 29~ 2JN 2JY 2LR 2P1 2VQ 2~H 36B 4.4 406 40D 53G 5GY 5QI 5RE 5VS 6NX 78A 7RV 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8UJ 95- 95. 95~ AACDK AAHNG AAIAL AAJBT AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDBF ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABLJU ABMNI ABMQK ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACIWK ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACUHS ACZOJ ADBBV ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AFBBN AFDZB AFEXP AFFNX AFJLC AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGVAE AGWIL AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOCGG ARAPS AXYYD AYFIA AZFZN B-. B0M BA0 BBNVY BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DNIVK DPUIP DU5 EAD EAP EAS EBB EBC EBD EBLON EBO EBS EBX EHN EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPL EPT ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FSGXE FYUFA G-Y G-Z GGCAI GNWQR GQ7 GRRUI H13 HCIFZ HF~ HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ IWAJR IZIGR IZQ I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KPH LAS LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O9G OAM OVD P19 P62 P9S PF0 PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK Q~Q R89 R9I RNI RNS ROL RPX RSV RZK S1Z S26 S27 S28 S37 SAP SCLPG SDH SISQX SJYHP SMD SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 T13 T16 TEORI TH9 TSG TSK TT1 TUS UG4 UKHRP UOJIU UTJUX UZXMN VFIZW W23 W48 WK8 WOW YLTOR Z8Z ZMTXR ~8M AAYXX ABFSG ABRTQ ACSTC AEZWR AFHIU AHWEU AIXLP ATHPR CITATION PHGZM PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 |
ID | FETCH-LOGICAL-c326t-c22d0c407dc28d563f7190a1b1af48995a00bab75c262f7abb9791fc7624c2f13 |
ISSN | 1619-7070 1619-7089 |
IngestDate | Fri Sep 05 06:50:04 EDT 2025 Sat Aug 16 21:26:10 EDT 2025 Wed Jul 30 01:49:28 EDT 2025 Wed Oct 01 08:24:31 EDT 2025 Wed Apr 23 01:18:06 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Positron emission tomography (PET) NSCLC Histologic subtype Radiomics |
Language | English |
License | 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c326t-c22d0c407dc28d563f7190a1b1af48995a00bab75c262f7abb9791fc7624c2f13 |
Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-4084-5150 |
PMID | 39794511 |
PQID | 3193466143 |
PQPubID | 42802 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_3154403001 proquest_journals_3193466143 pubmed_primary_39794511 crossref_primary_10_1007_s00259_025_07069_6 springer_journals_10_1007_s00259_025_07069_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-05-01 |
PublicationDateYYYYMMDD | 2025-05-01 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | European journal of nuclear medicine and molecular imaging |
PublicationTitleAbbrev | Eur J Nucl Med Mol Imaging |
PublicationTitleAlternate | Eur J Nucl Med Mol Imaging |
PublicationYear | 2025 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | F Bray (7069_CR2) 2024; 74 Y Zhang (7069_CR24) 2024; 19 C Owens (7069_CR9) 2023; 96 X Tang (7069_CR17) 2022; 12 7069_CR36 H Li (7069_CR48) 2022; 26 M Tian (7069_CR8) 2021; 48 I Fornacon-Wood (7069_CR41) 2020; 30 X Sun (7069_CR13) 2022; 12 PF Whiting (7069_CR30) 2011; 155 Z Diao (7069_CR45) 2024; 174 Y Ji (7069_CR46) 2021; 13 L Papp (7069_CR43) 2019; 60 A Civelek (7069_CR50) 2017; 58 X Sha (7069_CR19) 2019; 8 X Zhu (7069_CR6) 2018; 28 B Zhao (7069_CR39) 2021; 11 H Zhao (7069_CR32) 2022; 12 MA Leger (7069_CR10) 2022; 52 K Barbouchi (7069_CR28) 2023; 33 SH Hyun (7069_CR20) 2019; 44 O Ayyildiz (7069_CR21) 2020; 28 C Ren (7069_CR16) 2021; 48 C Faivre-Finn (7069_CR11) 2020; 21 M Hatt (7069_CR35) 2023; 50 M Avanzo (7069_CR42) 2020; 47 WM Chen (7069_CR12) 2022; 305 7069_CR1 7069_CR3 M Egger (7069_CR31) 1997; 315 A Civelek (7069_CR51) 2017; 58 CH Chiu (7069_CR14) 2011; 6 M McNitt-Gray (7069_CR40) 2020; 6 M Bicakci (7069_CR44) 2020; 8 M Wang (7069_CR4) 2021; 27 H Shen (7069_CR18) 2021; 11 P Lambin (7069_CR15) 2017; 14 Y Ma (7069_CR23) 2018; 63 Y Zhou (7069_CR25) 2021; 48 H Zhao (7069_CR27) 2024; 31 K Chen (7069_CR47) 2023; 128 MJ Page (7069_CR29) 2021; 372 E Bębas (7069_CR34) 2021; 66 Z Khodabakhshi (7069_CR22) 2023; 35 FH van Velden (7069_CR38) 2016; 18 Y Han (7069_CR26) 2021; 48 H Hricak (7069_CR7) 2021; 22 DG Altman (7069_CR49) 2009; 338 M Hatt (7069_CR37) 2018; 45 X Tang (7069_CR33) 2022; 12 G Scagliotti (7069_CR5) 2009; 14 |
References_xml | – volume: 74 start-page: 229 year: 2024 ident: 7069_CR2 publication-title: CA: Cancer J Clin doi: 10.3322/caac.21834 – volume: 52 start-page: 707 year: 2022 ident: 7069_CR10 publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2022.04.010 – ident: 7069_CR3 doi: 10.1016/j.mayocp.2019.01.013 – volume: 96 start-page: 20220339 year: 2023 ident: 7069_CR9 publication-title: Br J Radiol doi: 10.1259/bjr.20220339 – volume: 18 start-page: 788 year: 2016 ident: 7069_CR38 publication-title: Mol Imaging Biol doi: 10.1007/s11307-016-0940-2 – volume: 13 start-page: 307 year: 2021 ident: 7069_CR46 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S287128 – volume: 315 start-page: 629 year: 1997 ident: 7069_CR31 publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 60 start-page: 864 year: 2019 ident: 7069_CR43 publication-title: J Nucl Med doi: 10.2967/jnumed.118.217612 – volume: 305 start-page: 219 year: 2022 ident: 7069_CR12 publication-title: Radiology doi: 10.1148/radiol.212798 – volume: 66 start-page: 102446 year: 2021 ident: 7069_CR34 publication-title: Biomed Signal Process Control doi: 10.1016/j.bspc.2021.102446 – volume: 6 start-page: 118 year: 2020 ident: 7069_CR40 publication-title: Tomography doi: 10.18383/j.tom.2019.00031 – volume: 50 start-page: 352 year: 2023 ident: 7069_CR35 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-022-06001-6 – volume: 174 start-page: 108461 year: 2024 ident: 7069_CR45 publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2024.108461 – volume: 48 start-page: 1538 year: 2021 ident: 7069_CR16 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-020-05065-6 – volume: 31 start-page: 35 year: 2024 ident: 7069_CR27 publication-title: Acad Radiol doi: 10.1016/j.acra.2023.03.032 – volume: 12 start-page: 875761 year: 2022 ident: 7069_CR32 publication-title: Front Oncol doi: 10.3389/fonc.2022.875761 – volume: 33 start-page: 1383 year: 2023 ident: 7069_CR28 publication-title: Int J Imaging Syst Technol doi: 10.1002/ima.22858 – volume: 45 start-page: 630 year: 2018 ident: 7069_CR37 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3865-3 – volume: 12 start-page: 991102 year: 2022 ident: 7069_CR17 publication-title: Front Oncol doi: 10.3389/fonc.2022.991102 – volume: 48 start-page: 2904 year: 2021 ident: 7069_CR25 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05220-7 – volume: 30 start-page: 6241 year: 2020 ident: 7069_CR41 publication-title: Eur Radiol doi: 10.1007/s00330-020-06957-9 – volume: 22 start-page: e136 year: 2021 ident: 7069_CR7 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30751-8 – volume: 12 start-page: 803824 year: 2022 ident: 7069_CR33 publication-title: Front Oncol doi: 10.3389/fonc.2022.803824 – volume: 28 start-page: 262 year: 2020 ident: 7069_CR21 publication-title: Turk J Electr Eng Co doi: 10.3906/elk-1810-154 – volume: 26 start-page: 4563 year: 2022 ident: 7069_CR48 publication-title: IEEE J Biomed Health Inf doi: 10.1109/JBHI.2022.3192010 – volume: 21 start-page: 481 year: 2020 ident: 7069_CR11 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30108-X – volume: 155 start-page: 529 year: 2011 ident: 7069_CR30 publication-title: Ann Intern Med doi: 10.7326/0003-4819-155-8-201110180-00009 – volume: 8 start-page: 218470 year: 2020 ident: 7069_CR44 publication-title: IEEE Access doi: 10.1109/ACCESS.2020.3040155 – volume: 28 start-page: 2772 year: 2018 ident: 7069_CR6 publication-title: Eur Radiol doi: 10.1007/s00330-017-5221-1 – volume: 6 start-page: 1697 year: 2011 ident: 7069_CR14 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e318226b677 – volume: 63 start-page: 165018 year: 2018 ident: 7069_CR23 publication-title: Phys Med Biol doi: 10.1088/1361-6560/aad648 – volume: 47 start-page: e185 year: 2020 ident: 7069_CR42 publication-title: Med Phys doi: 10.1002/mp.13678 – ident: 7069_CR36 doi: 10.21203/rs.3.rs-2393890/v1 – volume: 14 start-page: 253 year: 2009 ident: 7069_CR5 publication-title: Oncologist doi: 10.1634/theoncologist.2008-0232 – volume: 58 start-page: 1343 issue: supplement 1 year: 2017 ident: 7069_CR50 publication-title: J Nucl Med – volume: 19 start-page: e0300170 year: 2024 ident: 7069_CR24 publication-title: PLoS ONE doi: 10.1371/journal.pone.0300170 – volume: 58 start-page: 455 issue: supplement 1 year: 2017 ident: 7069_CR51 publication-title: J Nucl Med – volume: 14 start-page: 749 year: 2017 ident: 7069_CR15 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2017.141 – volume: 338 start-page: b605 year: 2009 ident: 7069_CR49 publication-title: BMJ doi: 10.1136/bmj.b605 – volume: 12 start-page: e056804 year: 2022 ident: 7069_CR13 publication-title: BMJ Open doi: 10.1136/bmjopen-2021-056804 – volume: 27 start-page: 1345 year: 2021 ident: 7069_CR4 publication-title: Nat Med doi: 10.1038/s41591-021-01450-2 – volume: 8 start-page: 1741 year: 2019 ident: 7069_CR19 publication-title: Transl Cancer Res doi: 10.21037/tcr.2019.08.20 – volume: 35 start-page: 713 year: 2023 ident: 7069_CR22 publication-title: Clin Oncol doi: 10.1016/j.clon.2023.08.003 – volume: 48 start-page: 350 year: 2021 ident: 7069_CR26 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-020-04771-5 – volume: 11 start-page: 2918 year: 2021 ident: 7069_CR18 publication-title: Quant Imaging Med Surg doi: 10.21037/qims-20-1182 – volume: 11 start-page: 633176 year: 2021 ident: 7069_CR39 publication-title: Front Oncol doi: 10.3389/fonc.2021.633176 – volume: 128 start-page: 537 year: 2023 ident: 7069_CR47 publication-title: Radiol Med doi: 10.1007/s11547-023-01621-w – volume: 372 start-page: n160 year: 2021 ident: 7069_CR29 publication-title: BMJ doi: 10.1136/bmj.n160 – volume: 44 start-page: 956 year: 2019 ident: 7069_CR20 publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000002810 – volume: 48 start-page: 2338 year: 2021 ident: 7069_CR8 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05234-1 – ident: 7069_CR1 doi: 10.3322/caac.21820 |
SSID | ssj0018289 |
Score | 2.463022 |
SecondaryResourceType | review_article |
Snippet | Purpose
To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung... To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer... PurposeTo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2212 |
SubjectTerms | Adenocarcinoma Carcinoma, Non-Small-Cell Lung - classification Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - pathology Cardiology Classification Confidence intervals Heterogeneity Humans Image Processing, Computer-Assisted - methods Imaging Lung cancer Lung Neoplasms - classification Lung Neoplasms - diagnostic imaging Lung Neoplasms - pathology Medicine Medicine & Public Health Meta-analysis Non-small cell lung carcinoma Nuclear Medicine Oncology Orthopedics Positron-Emission Tomography Quality assessment Quality control Radiology Radiomics Review Article Small cell lung carcinoma Squamous cell carcinoma Statistical analysis Statistical models Subgroups |
Title | PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis |
URI | https://link.springer.com/article/10.1007/s00259-025-07069-6 https://www.ncbi.nlm.nih.gov/pubmed/39794511 https://www.proquest.com/docview/3193466143 https://www.proquest.com/docview/3154403001 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1619-7089 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0018289 issn: 1619-7070 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZCmMvY9_L1g0N9uap2LJsx3trR0sptOwhZdmTkWSbBZpkJDaM_aP7d3YnyXZcN7DuRSSKkBXdz6e7030Q8nEaBgVIxYLloZAMTijBFA9CpiIsb1yAiCAwwPnyKj6_FhfzaD4a_dnxWqordaR_3xlX8j9UhT6gK0bJ3oOy7aTQAZ-BvtAChaH9Jxp_PZ15G5kvMLLY5FWw6YMNO_O2tTL2VY3yMToEtcIhaPxsu8Q7aTTbezc1xt0i9Tc29Pl2dmfrNLwsKsmky2Gy16DvhNsVpkmWm_bq3s7QlOL1FktTHGlgtb6oAUN39M8Xcv2jXnT9zpH4e4ftb80UzbzOlMGjznGwZ8r09mX6QgYNCh9LfFts5KjY7bOliBquHvEd9PZYNHd-24X7amO4B0eJ9R7Bql1RysxiEz9O2a283a0iZVI_m8EZNJkZnMUPyAFPYpGMycHx2cnJVXvBhYou2gKav-PiuUxU5-CRfZlpoAgNLvGNbDR7Qh47pYYeW4Q-JaNi9Yw8vHS0f05-AVBpC1QKQKUdUKkDKu0Dla5L2gKVIlApApVaoH6mknYwpRamFEBGezB9Qa7PTmdfzpkr-cE06BEV05znvhZ-kms-zaM4LBOQWGWgAlmKaZpG0veVVEmkeczLRCqVJmlQajjSheZlEL4kY1hb8ZrQWJcqLHmai4SLSObSL6epymOlQ1Qz-IR4zaZmP21ml2w_ISfksNn3zL1N2wyOr1CggBtOyIf2Z-DPuClyVaxrHINcLwSST8grS6_2cXinjvkBJ-RTQ8Bu8v1reXO_4W_Jo-5lOyTjalMX70CSrtR7h8q_mc3HYQ |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET+radiomics+for+histologic+subtype+classification+of+non-small+cell+lung+cancer%3A+a+systematic+review+and+meta-analysis&rft.jtitle=European+journal+of+nuclear+medicine+and+molecular+imaging&rft.au=Zhang%2C+Jucheng&rft.au=Zhang%2C+Xiaohui&rft.au=Zhong%2C+Yan&rft.au=Wang%2C+Jing&rft.date=2025-05-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=1619-7070&rft.eissn=1619-7089&rft.volume=52&rft.issue=6&rft.spage=2212&rft.epage=2224&rft_id=info:doi/10.1007%2Fs00259-025-07069-6&rft.externalDocID=10_1007_s00259_025_07069_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1619-7070&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1619-7070&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1619-7070&client=summon |